Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
Kausik K. Ray, Harold Bays, Alberico L. Catapano, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 11, pp. 1022-1032
Open Access | Times Cited: 665

Showing 1-25 of 665 citing articles:

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
European Heart Journal (2019) Vol. 41, Iss. 1, pp. 111-188
Open Access | Times Cited: 6973
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
Atherosclerosis (2019) Vol. 290, pp. 140-205
Open Access | Times Cited: 4191
The changing landscape of atherosclerosis
Peter Libby
Nature (2021) Vol. 592, Iss. 7855, pp. 524-533
Closed Access | Times Cited: 1691
The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj, Brendan D. Manning
Nature reviews. Cancer (2019) Vol. 20, Iss. 2, pp. 74-88
Open Access | Times Cited: 1535
Targeting cancer metabolism in the era of precision oncology
Zachary E. Stine, Zachary T. Schug, Joseph M. Salvino, et al.
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 2, pp. 141-162
Open Access | Times Cited: 761
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
Nikolaus Marx, Massimo Federici, Katharina Schütt, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4043-4140
Open Access | Times Cited: 716
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Salim S. Virani, L. Kristin Newby, Suzanne V. Arnold, et al.
Circulation (2023) Vol. 148, Iss. 9
Open Access | Times Cited: 597
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
Steven E. Nissen, A. Michael Lincoff, Danielle M. Brennan, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 15, pp. 1353-1364
Closed Access | Times Cited: 539
2024 ESC Guidelines for the management of chronic coronary syndromes
Christiaan Vrints, Felicita Andreotti, Konstantinos C. Koskinas, et al.
European Heart Journal (2024) Vol. 45, Iss. 36, pp. 3415-3537
Open Access | Times Cited: 525
New insights into activation and function of the AMPK
Gregory R. Steinberg, D. Grahame Hardie
Nature Reviews Molecular Cell Biology (2022) Vol. 24, Iss. 4, pp. 255-272
Closed Access | Times Cited: 489
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease
Anne C. Goldberg, Lawrence A. Leiter, Erik S.G. Stroes, et al.
JAMA (2019) Vol. 322, Iss. 18, pp. 1780-1780
Open Access | Times Cited: 392
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du, Chan Liu, Mengyao Qin, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 558-580
Open Access | Times Cited: 367
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
Donald M. Lloyd‐Jones, Pamela B. Morris, Christie M. Ballantyne, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 14, pp. 1366-1418
Open Access | Times Cited: 305
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Christie M. Ballantyne, Ulrich Laufs, Kausik K. Ray, et al.
European Journal of Preventive Cardiology (2019) Vol. 27, Iss. 6, pp. 593-603
Open Access | Times Cited: 297
Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease
Erin D. Michos, John W. McEvoy, Roger S. Blumenthal
New England Journal of Medicine (2019) Vol. 381, Iss. 16, pp. 1557-1567
Closed Access | Times Cited: 291
Mendelian Randomization Study of ACLY and Cardiovascular Disease
Brian A. Ference, Kausik K. Ray, Alberico L. Catapano, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 11, pp. 1033-1042
Open Access | Times Cited: 284
Lipogenesis inhibitors: therapeutic opportunities and challenges
Battsetseg Batchuluun, Stephen L. Pinkosky, Gregory R. Steinberg
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 4, pp. 283-305
Open Access | Times Cited: 271
Acute coronary syndromes
Brian A. Bergmark, Njambi Mathenge, Piera Angelica Merlini, et al.
The Lancet (2022) Vol. 399, Iss. 10332, pp. 1347-1358
Open Access | Times Cited: 271
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
Josefin Soppert, Michael Lehrke, Nikolaus Marx, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 4-33
Open Access | Times Cited: 259
Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction
Paolo Severino, Andrea D’Amato, Mariateresa Pucci, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8118-8118
Open Access | Times Cited: 256
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Yajun Duan, Ke Gong, Suowen Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 249
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
Salim S. Virani, L. Kristin Newby, Suzanne V. Arnold, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 9, pp. 833-955
Open Access | Times Cited: 224
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 207
Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
Mary P. McGowan, Seyed Hamed Hosseini Dehkordi, Patrick M. Moriarty, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 24
Open Access | Times Cited: 204
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary
Yehuda Handelsman, Paul S. Jellinger, Chris Guerin, et al.
Endocrine Practice (2020) Vol. 26, Iss. 10, pp. 1196-1224
Closed Access | Times Cited: 203
Page 1 - Next Page

Scroll to top